Sonic Fund Ii, L.P. Regenxbio Inc. Transaction History

Sonic Fund Ii, L.P.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	BUY	$30.19 - $40.28 $129,605 - $172,922	4,293 Added 2.27%	193,079 $6.31 Million
Q3 2021 Nov 15, 2021	SELL	$29.09 - $45.68 $2.18 Million - $3.43 Million	-75,000 Reduced 28.43%	188,786 $7.91 Million
Q2 2021 Aug 16, 2021	BUY	$32.46 - $40.48 $8.56 Million - $10.7 Million	263,786 New	263,786 $10.2 Million
Q2 2021 Aug 16, 2021	SELL	$32.46 - $40.48 $8.56 Million - $10.7 Million	-263,786 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$27.01 - $40.26 $4.1 Million - $6.11 Million	-151,878 Reduced 36.54%	263,786 $7.26 Million
Q2 2020 Aug 14, 2020	SELL	$27.75 - $43.44 $1.39 Million - $2.17 Million	-50,000 Reduced 10.74%	415,664 $15.3 Million
Q4 2019 Feb 14, 2020	BUY	$34.54 - $44.87 $16.1 Million - $20.9 Million	465,664 New	465,664 $19.1 Million

196

43M

104K

478K

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $329M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

Get notified when there are updates to the investment portfolio of Sonic Fund Ii, L.P., based on Form 13F filings with the SEC.

Stay updated on Sonic Fund Ii, L.P. with notifications on news.